Literature DB >> 8866641

Elimination half-life of vitamin K1 in neonates is longer than is generally assumed: implications for the prophylaxis of haemorrhaghic disease of the newborn.

K Stoeckel1, P H Joubert, J Grüter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8866641     DOI: 10.1007/bf00203790

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  10 in total

1.  Effects of oral and intramuscular vitamin K prophylaxis on vitamin K1, PIVKA-II, and clotting factors in breast fed infants.

Authors:  E A Cornelissen; L A Kollée; R A De Abreu; J M van Baal; K Motohara; B Verbruggen; L A Monnens
Journal:  Arch Dis Child       Date:  1992-10       Impact factor: 3.791

2.  Pharmacokinetics and safety of a new solution of vitamin K1(20) in children with cholestasis.

Authors:  O Amédée-Manesme; W E Lambert; D Alagille; A P De Leenheer
Journal:  J Pediatr Gastroenterol Nutr       Date:  1992-02       Impact factor: 2.839

3.  Plasma concentrations of vitamin K1 and PIVKA-II in bottle-fed and breast-fed infants with and without vitamin K prophylaxis at birth.

Authors:  J Widdershoven; W Lambert; K Motohara; L Monnens; A de Leenheer; I Matsuda; F Endo
Journal:  Eur J Pediatr       Date:  1988-11       Impact factor: 3.183

Review 4.  Neonatal vitamin K prophylaxis. Report of Scientific and Standardization Subcommittee on Perinatal Haemostasis.

Authors:  R von Kries; Y Hanawa
Journal:  Thromb Haemost       Date:  1993-03-01       Impact factor: 5.249

5.  Oral vitamin K in breast-fed infants to prevent late haemorrhagic disease of the newborn.

Authors:  P H Joubert; K Stoeckel
Journal:  Lancet       Date:  1994-08-13       Impact factor: 79.321

6.  Oral vitamin K prophylaxis and late haemorrhagic disease of the newborn.

Authors:  R von Kries; U Göbel
Journal:  Lancet       Date:  1994-02-05       Impact factor: 79.321

7.  Severe vitamin K deficiency in breast-fed infants.

Authors:  K Motohara; M Matsukura; I Matsuda; K Iribe; T Ikeda; Y Kondo; A Yonekubo; Y Yamamoto; F Tsuchiya
Journal:  J Pediatr       Date:  1984-12       Impact factor: 4.406

8.  Plasma concentrations after oral or intramuscular vitamin K1 in neonates.

Authors:  A W McNinch; C Upton; M Samuels; M J Shearer; P McCarthy; J H Tripp; R L'E Orme
Journal:  Arch Dis Child       Date:  1985-09       Impact factor: 3.791

9.  Vitamin K1 concentration in breast-fed neonates after oral or intramuscular administration of a single dose of a new mixed-micellar preparation of phylloquinone.

Authors:  G Schubiger; O Tönz; J Grüter; M J Shearer
Journal:  J Pediatr Gastroenterol Nutr       Date:  1993-05       Impact factor: 2.839

10.  Haemorrhagic disease of the newborn in the British Isles: two year prospective study.

Authors:  A W McNinch; J H Tripp
Journal:  BMJ       Date:  1991-11-02
  10 in total
  5 in total

Review 1.  The neonatal coagulation system and the vitamin K deficiency bleeding - a mini review.

Authors:  Ewald Pichler; Ludwig Pichler
Journal:  Wien Med Wochenschr       Date:  2008

2. 

Authors:  Eugene Ng; Amanda D Loewy
Journal:  Can Fam Physician       Date:  2018-10       Impact factor: 3.275

3.  Position Statement: Guidelines for vitamin K prophylaxis in newborns: A joint statement of the Canadian Paediatric Society and the College of Family Physicians of Canada.

Authors:  Eugene Ng; Amanda D Loewy
Journal:  Can Fam Physician       Date:  2018-10       Impact factor: 3.275

4.  Intestinal absorption of mixed micellar phylloquinone (vitamin K1) is unreliable in infants with conjugated hyperbilirubinaemia: implications for oral prophylaxis of vitamin K deficiency bleeding.

Authors:  S P Pereira; M J Shearer; R Williams; G Mieli-Vergani
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-03       Impact factor: 5.747

Review 5.  Vitamin K in neonates: how to administer, when and to whom.

Authors:  E Autret-Leca; A P Jonville-Béra
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.930

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.